These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Heart disease risk factors and hormone use in postmenopausal women. Barrett-Connor E; Brown WV; Turner J; Austin M; Criqui MH JAMA; 1979 May; 241(20):2167-9. PubMed ID: 430817 [TBL] [Abstract][Full Text] [Related]
7. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. Bradley DD; Wingerd J; Petitti DB; Krauss RM; Ramcharan S N Engl J Med; 1978 Jul; 299(1):17-20. PubMed ID: 207983 [TBL] [Abstract][Full Text] [Related]
8. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499 [TBL] [Abstract][Full Text] [Related]
9. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population. Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124 [TBL] [Abstract][Full Text] [Related]
10. Complications of oral contraceptive agents-a symposium. Effects of oral contraceptives on carbohydrate metabolism. Bray GA West J Med; 1975 Jan; 122(1):33-5. PubMed ID: 1089004 [No Abstract] [Full Text] [Related]
11. The Royal College of General Practitioners' Oral Contraception Study: some recent observations. Kay CR Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858 [TBL] [Abstract][Full Text] [Related]
12. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629 [TBL] [Abstract][Full Text] [Related]
13. Effects of oral contraceptives and obesity on protein C antigen. Meade TW; Stirling Y; Wilkes H; Mannucci PM Thromb Haemost; 1985 Apr; 53(2):198-9. PubMed ID: 3839605 [TBL] [Abstract][Full Text] [Related]
16. [Myocardial infarct and ovulation inhibitors]. Zimmermann KG; Siegenthaler W Dtsch Med Wochenschr; 1975 Jun; 100(26):1441-3. PubMed ID: 1149628 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group. Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251 [TBL] [Abstract][Full Text] [Related]
18. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
19. [The correlation of blood pressure, cholesterol and triglyceride concentration with the administration of hormonal contraceptives in women from 2 Erfurt large-scale plants]. Heinrich J; Knappe J; Gräfner L; Holtz H; Rühling K; Schauer I; Dück KD; Strube G Z Gesamte Inn Med; 1979 Sep; 34(18):540-4. PubMed ID: 516840 [TBL] [Abstract][Full Text] [Related]
20. Pill formulations and their effect on lipid and carbohydrate metabolism. Brooks PG J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]